Engitix Therapeutics

Engitix Therapeutics is a biotechnology company that focuses on the extracellular matrix (ECM) to discover novel therapeutic targets for fibrosis and cancer. By leveraging a proprietary platform that integrates proteomics and transcriptomics with clinical data, we aim to identify and validate innovative treatment avenues within the tumor microenvironment and fibrotic tissue.